IT1293583B1 - Treating demential syndromes comprising administration of gammahydroxybutyric acid - Google Patents
Treating demential syndromes comprising administration of gammahydroxybutyric acidInfo
- Publication number
- IT1293583B1 IT1293583B1 IT97MI001613A ITMI971613A IT1293583B1 IT 1293583 B1 IT1293583 B1 IT 1293583B1 IT 97MI001613 A IT97MI001613 A IT 97MI001613A IT MI971613 A ITMI971613 A IT MI971613A IT 1293583 B1 IT1293583 B1 IT 1293583B1
- Authority
- IT
- Italy
- Prior art keywords
- demential
- treating
- syndromes
- administration
- gammahydroxybutyric
- Prior art date
Links
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The therapeutic method for treating demential syndromes comprises administering a therapeutically effective amount of gammahydroxybutyric acid (or pharmaceutically acceptable salt).
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001613A IT1293583B1 (en) | 1997-07-07 | 1997-07-07 | Treating demential syndromes comprising administration of gammahydroxybutyric acid |
CA 2217902 CA2217902A1 (en) | 1997-07-07 | 1997-10-08 | Use of gammahydroxybutyrric acid for the treatment of demential syndromes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001613A IT1293583B1 (en) | 1997-07-07 | 1997-07-07 | Treating demential syndromes comprising administration of gammahydroxybutyric acid |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI971613A0 ITMI971613A0 (en) | 1997-07-07 |
ITMI971613A1 ITMI971613A1 (en) | 1999-01-07 |
IT1293583B1 true IT1293583B1 (en) | 1999-03-08 |
Family
ID=11377515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT97MI001613A IT1293583B1 (en) | 1997-07-07 | 1997-07-07 | Treating demential syndromes comprising administration of gammahydroxybutyric acid |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2217902A1 (en) |
IT (1) | IT1293583B1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013024028A1 (en) * | 2011-08-12 | 2013-02-21 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds and compositions for treating proteinopathies |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (en) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
CA3127871A1 (en) | 2019-03-01 | 2020-09-10 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
-
1997
- 1997-07-07 IT IT97MI001613A patent/IT1293583B1/en active IP Right Grant
- 1997-10-08 CA CA 2217902 patent/CA2217902A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2217902A1 (en) | 1999-01-07 |
ITMI971613A0 (en) | 1997-07-07 |
ITMI971613A1 (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI946173A0 (en) | A method for improving the efficacy of drug delivery using modified saponins | |
CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
ZA977783B (en) | Method of inhibiting fibrosis with a somatostatin agonist | |
EP1033998A4 (en) | Method of suppressing beta-amyloid-related changes in alzheimer's disease | |
GB2303064B (en) | Medicament for nasal administration | |
EP1086702A3 (en) | Method for reduction of headache pain | |
HUP0000558A3 (en) | Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases | |
HK1009939A1 (en) | Medicament for treating cardiac inflammatory diseases | |
HK1018012A1 (en) | Inhaler for administering medicaments from blisterpacks | |
EP1555025A3 (en) | Use of dehydroepiandrosterone analogs for the treatment of asthma | |
EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
CA2125662A1 (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
HK1034446A1 (en) | Therapeutic agents. | |
IT1293583B1 (en) | Treating demential syndromes comprising administration of gammahydroxybutyric acid | |
AU3046897A (en) | Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders | |
SE9703929D0 (en) | Therapeutic use and method | |
EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
EP0689839A3 (en) | Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide | |
HK1028545A1 (en) | Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms | |
IL146962A0 (en) | Aminotetralin derivatives for the therapy of cardiovascular diseases | |
ZA96260B (en) | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts | |
EP0872239A3 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
CA2237643A1 (en) | Therapeutic agent for acute hepatic failure | |
WO2000010544A3 (en) | A method for preventing the onset of asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |